Bay Colony Advisory Group, Inc D Stryker Corp Transaction History

Bay Colony Advisory Group, Inc D

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$324.3 - $354.67 $32,105 - $35,112	-99 Reduced 11.34%	774 $263,000
Q1 2024 Apr 30, 2024	BUY	$293.94 - $358.71 $256,609 - $313,153	873 New	873 $312,000
Q2 2023 Aug 11, 2023	SELL	$271.49 - $305.09 $23,076 - $25,932	-85 Reduced 6.49%	1,224 $373,000
Q1 2023 Apr 27, 2023	BUY	$246.13 - $285.47 $82,453 - $95,632	335 Added 34.39%	1,309 $373,000
Q4 2022 Feb 01, 2023	BUY	$205.51 - $253.93 $200,166 - $247,327	974 New	974 $238,000
Q3 2018 Nov 05, 2018	SELL	$163.25 - $177.68 $5,550 - $6,041	-34 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$155.17 - $179.78 $5,275 - $6,112	34 New	34 $6,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.